Product Name |
MF |
CAS |
Details |
Ivabradine chloro Impurity
3-(3-chloropropy)-7,8-dimethoxy-1,3-dihydro-2H-
benzo[d]azepin-2-one |
C15H18ClNO3 |
85175-59-3 |
|
Lidocaine EP Impurity H
Lidocaine USP Related Compound H ; 2-Chloro-N- (2,6-dimethylphenyl)acetamide |
C10H12ClNO |
1131-01-7 |
|
Diclofenac EP Impurity D
2-[2-[(2-Bromo-6-chlorophenyl) amino]phenyl] acetic acid |
C14H10BrClNNaO2 |
127792-45-4 |
|
Pantoprazole EP Impurity D
Pantoprazole Related Compound D and F Mixture ; 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2- yl)methyl)sulfinyl)-1-methyl-1H-benzo[d]imidazole |
C17H17F2N3O4S |
624742-53-6 |
|
Omeprazole EP Impurity E
Omeprazole USP RC E ; Esomeprazole EP Impurity E ;
Omeprazole N-Oxide |
C17H19N3O4S |
176219-04-8 |
|
Esomeprazole EP Impurity E
Omeprazole EP Impurity E ; Omeprazole N-Oxide ; Omeprazole
USP Related Compound E |
C17H19N3O4S |
176219-04-8 |
|
(S)-Hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione |
C7H10N2O2 |
3705-27-9 |
|
4-Amino-N-[4- (trifluoromethyl)phenyl]benzamide/Teriflunomide Impurity 3 |
C14H11F3N2O |
1011244-72-6 |
|
Teriflunomide Impurity 3
4-amino-N-(4-(trifluoromethyl)phenyl)benzamide |
C14H11F3N2O |
1011244-72-6 |
|
Propylparaben
propyl 4-hydroxybenzoate |
C10H12O3 |
94-13-3 |
|
Methylparaben
methyl 4-hydroxybenzoate |
C8H8O3 |
99-76-3 |
|
Gliclazide Impurity 1
hexahydrocyclopenta[c]pyrrol-2(1H)-amine hydrochloride |
C7H15ClN2 |
58108-05-7 |
|
Metamizole EP Impurity E
Dipirone Impurity E ;
((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4- yl)amino)methanesulfonic acid |
C12H15N3O4S |
117-38-4 |
|
Albendazole
Methyl 5-propylthio-2-benzimidazolecarbamate |
C12H15N3O2S |
54965-21-8 |
|
ketoprofen EP impurity C
3-(1-carboxyethyl)benzoic acid |
C10H10O4 |
68432-95-1 |
|
Leflunomide EP Impurity B
Leflunomide USP RC B ; (Z)-2-cyano-3-hydroxy-N-(4- (trifluoromethyl)
phenyl)but-2-enamide |
C12H9F3N2O2 |
163451-81-8 |
|
Febuxostat Methyl Ester
Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate |
C17H18N2O3S |
923942-34-1 |
|
Pregabalin EP Impurity B
USP Pregabalin Related Compound A ; (R)-3-(aminomethyl)-5-
methylhexanoic acid |
C8H17NO2 |
148553-51-9 |
|
Zonisamide
1,2-Benzisoxazole-3-methanesulfonamide |
C8H8N2O3S |
68291-97-4 |
|
Fenticonazole Nitrate EP Impurity B
1-(2-(2,4-dichlorophenyl)-2-((4-(phenylsulfinyl)benzyl)oxy)ethyl)
-1H-imidazole nitrate |
C24H21Cl2N3O5S |
80639-95-8 |
|
ketoprofen EP impurity E
2-(3-benzoylphenyl)propanamide |
C16H15NO2 |
59512-16-2 |
|
Bumetanide Impurity 1
Methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate |
C14H12N2O7S |
57939-04-5 |
|
N-Methyl Zonisamide
N-Methyl-1,2-benzisoxazole-3-methanesulfonamide |
C9H10N2O3S |
68292-02-4 |
|
Metronidazole EP impurity A
2-methyl-5-nitro-1H-imidazole |
C4H5N3O2 |
696-23-1 |
|
Cetirizine EP Impurity C
Cetirizine 2-Chloro Analog (RS)-2-[2-[4-[(2-
Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid |
C21H25ClN2O3 |
83881-59-8 |
|
2-Chloro BHP Cetirizine
1-[(2-Chlorophenyl)phenylmethyl]piperazine |
C17H19ClN2 |
109036-15-9 |
|
Ranolazine Related Compound B
Ranolazine Desmethoxy Impurity ;
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-
phenoxypropyl)piperazin-1-yl)acetamide |
C23H31N3O3 |
755711-09-2 |
|
Labetalol EP Impurity A 2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2-yl)amino)ethyl)benzoic acid |
C19H23NO4 |
1391051-99-2 |
|
Cetirizine Ethyl Ester
Cetirizine Dihydrochloride Ethyl Ester ; (RS)-2-[2-[4-[(4- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester |
C23H29ClN2O3 |
246870-46-2 |
|
Nabumetone EP Impurity F
6,6'-dimethoxy-2,2'-binaphthalenyl |
C22H18O2 |
29619-45-2 |
|
Ranolazine Dimer Impurity
α,α’-Bis[(2-Methoxyphenoxy)methyl]-1,4-piperazinediethanol |
C24H34N2O6 |
333749-57-8 |
|
(R)-Sitagliptin N-Boc-Methyl-Ester Impurity methyl (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl)butanoate |
C16H20F3NO4 |
881995-73-9 |
|
Gliclazide EP Impurity D
Gliclazide BP Impurity D;N-[(4- Methylphenyl)sulfonylhexahydrocyclopenta[c] pyrrol-2(1H)-carboxamide |
C15H20N2O3S |
1136426-19-1 |
|
Febuxostat Impurity 8
2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic
acid |
C16H17NO4S |
144060-62-8 |
|
Duloxetine EP Impurity D
α-Napthol (USP) ; Naphthalen-1-ol |
C10H8O |
90-15-3 |
|
Metolazone EP Impurity C
Metolazone USP RC A ; Desmethyl metolazone ;
7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-phenyl-6-
quinazolinesulfonamide |
C15H14ClN3O3S |
28524-40-5 |
|
Bisoprolol EP Impurity N
(2RS)-1-[4-((2-Ethoxyethoxy)methyl)phenoxy]-3- (isopropylamino)-2-propanol |
C17H29NO4 |
1346601-75-9 |
|
Prucalopride impurity B
4-amino-5-chloro-2,3dihydro-1-benzofuran7-carboxamide |
C9H9ClN2O2 |
182808-16-8 |
|
Febuxostat Isopropyl Ester
Isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate |
C19H22N2O3S |
1346238-10-5 |
|
Ranolazine impurity C
1-(2-methoxyphenoxy)-3-(piperazin-1-yl)propan-2-ol |
C14H22N2O3 |
162712-35-8 |
|
Mesalazine EP Impurity M
2-chloro-5-nitrobenzoic acid, Mesalamine EP Impurity M |
C7H4ClNO4 |
2516-96-3 |
|
Prucalopride impurity D
Methyl 4-amino-5chloro-2,3dihydrobenzofuran7-carboxylate |
C10H10ClNO3 |
182808-04-4 |
|
Paracetamol EP Impurity A
N-(2-hydroxyphenyl)acetamide |
C8H9NO2 |
614-80-2 |
|
Duloxetine EP Impurity B
Duloxetine alcohol (USP) ; (1S)-3-(Methylamino)-1-(thiophen-2- yl)propan-1-ol |
C8H13NOS |
116539-55-0 |
|
Valganciclovir Hydrochloride
L-Valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-
3-hydroxy propyl ester hydrochloride |
C14H23ClN6O5 |
175865-59-5 |
|
Chlorzoxazone
5-Chloro-2-benzoxazolinone;5-Chloro-2-hydroxybenzoxazole |
C7H4ClNO2 |
95-25-0 |
|
Quetiapine DBTC Impurity Dibenzo[b,f][1,4]thiazepine-11-yl-chloride ; 11-Chloro- dibenzo[b,f][1,4] thiazepine |
C13H8ClNS |
13745-86-3 |
|
Pioglitazone hydrochloride
(RS)-5-(4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl)thiazolidine-2,4- dione hydrochloride |
C19H21ClN2O3S |
112529-15-4 |
|
Warfarin
2-Oxo-3-[(1RS)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-ol |
C19H16O4 |
81-81-2 |
|
4-(Methylamino)-3-nitrobenzoic acid |
C8H8N2O4 |
41263-74-5 |
|
Omeprazole Sodium
Sodium 5-methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2- yl)methyl] sulphinyl]-1H-benzimidazole monohydrate |
C17H20N3NaO3S |
95510-70-6 |
|
Levodopa EP Impurity D
(R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid ; D-Dopa |
C9H11NO4 |
5796-17-8 |
|
Esketamine EP Impurity B
(2RS)-2-(2-chlorophenyl)-2-hydroxycyclohexanone |
C12H13ClO2 |
1823362-29-3 |
|
Pirfenidone EP Impurity A
5-methylpyridin-2-amine |
C6H8N2 |
1603-41-4 |
|
Irbesartan EP Impurity A
Irbesartan USP Related Compound A |
C25H30N6O2 |
748812-53-5 |
|
Lacosamide EP Impurity I
(R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide |
C19H23N3O3 |
2295925-90-3 |
|
Glipizide EP Impurity A
Glipizide Related Compound A ;
[2-(4-Sulphamoylphenyl) ethyl] 5-methyl-pyrazine-2- carboxamide ; |
C14H16N4O3S |
33288-71-0 |
|
Melantonin USP Related Compound A
2-(5-methoxy-1H-indol-3-yl)ethan-1-amine |
C11H14N2O |
608-07-1 |
|
Cetirizne Related Compound B
Cetirizine Deschloro Ethanol Impurity ; 2-[4- (Diphenylmethyl)piperazin-1-yl]ethanol dihydrochloride |
C19H26Cl2N2O |
108983-83-1 |
|
Olmesartan Imidazole Diethyl Ester Impurity
2-Propyl-1H-imidazole-4,5-dicarboxylic acid diethyl ester |
C12H18N2O4 |
144689-94-1 |
|
Brexpiprazole Impurity 12
7-(4-(piperzin-1-yl)butoxy)quinolin-2(1H)-one |
C17H23N3O2 |
1849603-58-2 |
|
D-Aspartic Acid 4-Methyl Ester Hydrochloride
D-Aspartic Acid 4-Methyl Ester Hydrochloride |
C5H11ClNO4 |
22728-89-8 |
|
Gliclazide EP Impurity B Gliclazide BP ImpurityB;2-Nitroso- octahydrocyclopenta[c]pyrrole |
C7H12N2O |
54786-86-6 |
|
Bupivacaine EP Impurity B
(2RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide |
C14H20N2O |
15883-20-2 |
|
Donepezil Related Compound A
Donepezil Dehydro Impurity ; (E)-Dehydro Donepezil ;
(E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-
1-one |
C24H27NO3 |
145546-80-1 |
|
Tolterodine |
C22H31NO |
124937-51-5 |
|
Tropicamide EP Impurity A,
Tropicamide related compound A, N-(pyridin-4-
ylmethyl)ethanamine |
C8H12N2 |
33403-97-3 |
|
Carbamazepine
5H-Dibenzo[b,f]azepine-5-carboxamide |
C15H12N2O |
298-46-4 |
|
Oxcarbazepine EP Impurity A
5H-dibenzo[b,f]azepine-5-carboxamide |
C15H12N2O |
298-46-4 |
|
Piroxicam EP Impurity E
Ethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate |
C11H11NO5S |
24683-20-3 |
|
Febuxostat Impurity 2
ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate |
C18H21NO4S |
161798-03-4 |
|
Amlodipine EP Impurity D
3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)- 6-methylpyridine-3,5-dicarboxylate benzenesulfonate |
C20H23ClN2O5 |
113994-41-5 |
|
Pregabalin Related Compound C
4-isobutylpyrrolidin-2-one |
C8H15NO |
61312-87-6 |
|
Isosorbide
1,4:3,6-Dianhydro-D-glucitol |
C6H10O4 |
652-67-5 |
|
Allopurinol
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one |
C5H4N4O |
315-30-0 |
|
Losartan EP Impurity A
2-Butyl-4-chloro-1H-imidazole-5-methanol |
C8H13ClN2O |
79047-41-9 |
|
Paracetamol EP Impurity B
N-(4-hydroxyphenyl)propionamide |
C9H11NO2 |
1693-37-4 |
|
Celecoxib Hydrazine Impurity
4-Sulphonamido phenyl hydrazine hydrochloride |
C6H10ClN3O2S |
17852-52-7 |
|
Flecainide EP Impurity B
(RS)-(piperidin-2-yl)methanamine |
C6H14N2 |
22990-77-8 |
|
Montelukast EP Impurity B
Montelukast USP Related Compound F ; Montelukast Methylstyrene ; Anhydro Montelukast |
C35H34ClNO2S |
918972-54-0 |
|
Cetirizine N-Oxide
(RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-oxido-piperazin- 1-yl]ethoxy] acetic acid |
C21H25ClN2O4 |
1076199-80-8 |
|
Amlodipine EP impurity G
Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine- 3,5-dicarboxylate |
C17H18ClNO4 |
43067-01-2 |
|
Apixaban Impurity 3
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
C22H20N4O6 |
536759-91-8 |
|
Zonisamide Related Compound C
N,N-Dimethyl Formimidamide ;
(E)-N'-((benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N- dimethylformimidamide |
C11H13N3O3S |
1217201-89-2 |
|
Pantoprazole EP Impurity B
Pantoprazole Related Compound B ;
5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-
yl)methyl)thio)-1H-benzo[d]imidazole |
C16H15F2N3O3S |
102625-64-9 |
|
Irbesartan Hydroxy Impurity
Candesartan Hydroxy Impurity ; p-(o-1H-Tetrazol-5- ylphenyl)benzyl alcohol |
C14H12N4O |
160514-13-6 |
|
Bisoprolol EP Impurity K
2-isopropoxyethyl 4-(2-hydroxy-3-
(isopropylamino)propoxybenzoate |
C18H29NO5 |
864544-37-6 |
|
Celecoxib EP Impurity B
USP Related compound B ; 4-[3-(4-Methylphenyl)-5- trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide |
C17H14F3N3O2S |
331943-04-5 |
|
Nateglinide ethyl ester
N-(TRANS-4-ISOPROPYLCYCLOHEXYLCARBONAYL-D- PHENYLALANINE-ETHYLESTER |
C21H31NO3 |
187728-85-4 |
|
NATEGLINIDE IMPURITY-F
N-[[TRANS-4-(1-METHYLETHYL)CYCLOHEXYL]CARBONYL]-D-
PHENYLALANYL-D-PHENY LALANINE |
C28H36N2O4 |
944746-48-9 |
|
Apremilast
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)
-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide |
C22H24N2O7S |
608141-41-9 |
|
Metoprolol EP Impurity B
4-(2-Methoxyethyl)phenol |
C9H12O2 |
56718-71-9 |
|
N,N-Dimethylprop-2-ynamide |
C5H7NO |
2682-34-0 |
|
Azilsartan Ethyl Impurity
ethyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)
-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7- carboxylate |
C27H24N4O5 |
1403474-70-3 |
|
Teneligliptin HBr
[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]- 2-pyrrolidinyl]-3-thiazolidinylmethanone HBr |
C22H31BrN6OS |
906093-29-6 |
|
Tramadol EP Impurity C
1-(3'-methoxy-2,3,4,5-tetrahydro-[1,1'-biphenyl]-2-yl)-N,N- dimethylmethanamine hydrochloride |
C16H24ClNO |
66170-31-8 |
|
Diclofenac EP Impurity F
N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide |
C14H10Cl3NO |
560075-65-2 |
|
Levodopa EP Impurity B
L-tyrosine ; (2S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid |
C9H11NO3 |
60-18-4 |
|
Ranolazine Related Compound D
N,N’-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide |
C24H32N4O2 |
380204-72-8 |
|
ROSUVASTATIN IMPURITY-M |
C22H29N3O6S |
847849-66-5 |
|